Finance

Lists
Why is 301333 down 2,23%?
Dive Deeper
301333:SHE
R&G PharmaStudies Co Ltd
55,26 CN¥
-2,23%
(-1,26) 1D
16 հոկ, 15:04:19 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301333...
Open
57,59 CN¥
High
60,60 CN¥
Low
54,03 CN¥
Mkt. cap
5,34 մլրդ
Avg. vol.
2,82 մլն
Volume
2,70 մլն
Dividend
0,29%
Quarterly dividend
0,04 CN¥
Ex-dividend date
03 հլս, 2026 թ.
P/E ratio
44,22
52-wk high
91,78 CN¥
52-wk low
43,79 CN¥
EPS
1,25 CN¥
Shares outstanding
96,58 մլն
No. of employees
3 հզր
Open
57,59 CN¥
High
60,60 CN¥
Low
54,03 CN¥
Mkt. cap
5,34 մլրդ
Avg. vol.
2,82 մլն
Volume
2,70 մլն
Dividend
0,29%
Quarterly dividend
0,04 CN¥
Ex-dividend date
03 հլս, 2026 թ.
P/E ratio
44,22
52-wk high
91,78 CN¥
52-wk low
43,79 CN¥
EPS
1,25 CN¥
Shares outstanding
96,58 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
About R&G PharmaStudies Co Ltd
CEO-
Employees2,64 հզր
Founded22 օգս, 2008 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
227,71 մլն
243,64 մլն
218,09 մլն
249,87 մլն
Cost of goods sold
153,16 մլն
164,25 մլն
152,25 մլն
174,53 մլն
Cost of revenue
153,16 մլն
164,25 մլն
152,25 մլն
174,53 մլն
Research and development expenses
15,10 մլն
16,19 մլն
15,51 մլն
18,39 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,99 մլն
30,78 մլն
23,05 մլն
24,60 մլն
Operating expense
38,00 մլն
50,32 մլն
39,67 մլն
50,25 մլն
Total operating expenses
191,16 մլն
214,57 մլն
191,92 մլն
224,78 մլն
Operating income
36,55 մլն
29,07 մլն
26,18 մլն
25,09 մլն
Other non operating income
-1,56 մլն
1,43 մլն
-3,03 մլն
3,02 մլն
EBT including unusual items
39,46 մլն
45,33 մլն
25,76 մլն
24,43 մլն
EBT excluding unusual items
40,16 մլն
32,65 մլն
26,20 մլն
22,97 մլն
Income tax expense
4,17 մլն
3,87 մլն
2,88 մլն
1,95 մլն
Effective tax rate
10,56%
8,54%
11,16%
7,97%
Other operating expenses
1,04 մլն
1,05 մլն
1,01 մլն
1,30 մլն
Net income
34,45 մլն
41,33 մլն
22,83 մլն
21,64 մլն
Net profit margin
15,13%
16,96%
10,47%
8,66%
Earnings per share
-
-
-
-
Interest and investment income
5,23 մլն
6,24 մլն
3,65 մլն
1,47 մլն
Interest expense
-623,53 հզր
-623,36 հզր
-605,42 հզր
-567,67 հզր
Net interest expenses
4,61 մլն
5,62 մլն
3,05 մլն
906,53 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
38,49 մլն
30,77 մլն
27,88 մլն
26,74 մլն
Gain or loss from assets sale
-
9,34 հզր
-
-3,52 հզր
AI content may include mistakes. Learn more
Google Apps